Glycemic effects of rebaudioside a and erythritol in people with glucose intolerance

Diabetes and Metabolism Journal

Volumn 40, Issue 4, 2016, Pages 283-289

  Shin, Dong Hee ^a   Lee, Ji Hye ^a   Kang, Myung Shin ^a   Kim, Tae Hoon ^a   Jeong, Su Jin ^a   Kim, Chong Hwa ^a   Kim, Sang Soo ^b   Kim, In Joo ^b  

^a Sejong General Hospital   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

Author keywords

Erythritol; Glucose intolerance; Rebaudioside A

Indexed keywords

C PEPTIDE; ERYTHRITOL; FRUCTOSAMINE; GLUCOSE; NONNUTRITIVE SWEETENER; REBAUDIOSIDE A; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIDIABETIC ACTIVITY; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; EVENING DOSAGE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; HUMAN; MALE; MORNING DOSAGE;

EID: 84990840469     PISSN: 22336079     EISSN: 22336087     Source Type: Journal    
DOI: 10.4093/dmj.2016.40.4.283     Document Type: Article

References (28)

1. Kroger M, Meister K, Kava R. Low-calorie sweeteners and other sugar substitutes: a review of the safety issues. Compr Rev Food Sci Food Saf 2006;5:35-47.
2. ScienceDaily: Alternative sweeteners are increasing by 8% a year. Available from: http://www.sciencedaily.com/releases/2008/05/080512140912.htm (updated 2008 May 14).
3. World Health Organization. Evaluation of certain food additives (WHO technical report series 928): sixty-third report of the Joint FAO/WHO Expert Committee on Food Additives. Geneva: World Health Organization; 2005. p166.
4. Wood HB, Allerton R, Diehl HW, Fletcher HG. Stevioside. I. The structure of the glucose moieties. J Org Chem 1955;20: 875-83.
5. Pol J, Hohnova B, Hyotylainen T. Characterisation of Stevia rebaudiana by comprehensive two-dimensional liquid chromatography time-of-flight mass spectrometry. J Chromatogr A 2007;1150:85-92.
6. Roper H, Goossens J. Erythritol, a new raw material for food and non-food applications. Starch 1993;45:400-5.
7. Jeppesen PB, Gregersen S, Poulsen CR, Hermansen K. Stevioside acts directly on pancreatic beta cells to secrete insulin: actions independent of cyclic adenosine monophosphate and adenosine triphosphate-sensitive K+-channel activity. Metabolism 2000;49:208-14.
8. Gregersen S, Jeppesen PB, Holst JJ, Hermansen K. Antihyperglycemic effects of stevioside in type 2 diabetic subjects. Metabolism 2004;53:73-6.
9. Jeppesen PB, Gregersen S, Rolfsen SE, Jepsen M, Colombo M, Agger A, Xiao J, Kruhoffer M, Orntoft T, Hermansen K. Antihyperglycemic and blood pressure-reducing effects of stevioside in the diabetic Goto-Kakizaki rat. Metabolism 2003;52: 372-8.
10. Chen TH, Chen SC, Chan P, Chu YL, Yang HY, Cheng JT. Mechanism of the hypoglycemic effect of stevioside, a glycoside of Stevia rebaudiana. Planta Med 2005;71:108-13.
11. Ferri LA, Alves-Do-Prado W, Yamada SS, Gazola S, Batista MR, Bazotte RB. Investigation of the antihypertensive effect of oral crude stevioside in patients with mild essential hypertension. Phytother Res 2006;20:732-6.
12. Jeppesen PB, Barriocanal L, Meyer MT, Palacios M, Canete F, Benitez S, Logwin S, Schupmann Y, Benitez G, Jimenez JT. Efficacy and tolerability of oral stevioside in patients with type 2 diabetes: a long-term, randomized, doubleblinded, placebocontrolled study. Diabetologia 2006;49(Suppl 1):511-2.
13. Noda K. Analysis of metabolites in urine after single oral administration of NIK-242 to dogs. Omiya (JP): Division of Metabolism, Omiya Research Lab., Niken Chemicals Co. Ltd.; 1994.
14. Ishikawa M, Hirose C, Tsujino D, Miyashita M, Kawashima Y, Nakamura T. The effect of erythritol on glucose tolerance in diabetes patients. Yokohama (JP): Department of Metabolic Endocrinology and Department of Nutrition, Seibu Hospital, St. Marianna University School of Medicine; 1992.
15. Barriocanal L, Palacios M, Benitez S, Canete F, Jimenez JT, Jimenez N, Rojas V. Lack of pharmacological effect of steviol glycosides as a sweetener in humans. Studies on repeated exposures in normotensive and hypotensive individuals and type 1 and type 2 diabetes. Proceedings of the 2nd International Stevia Symposium; 2006 Nov 9-10; Asuncion, PY.
16. Abudula R, Matchkov VV, Jeppesen PB, Nilsson H, Aalkjaer C, Hermansen K. Rebaudioside A directly stimulates insulin secretion from pancreatic beta cells: a glucose-dependent action via inhibition of ATP-sensitive K-channels. Diabetes Obes Metab 2008;10:1074-85.
17. Mohd-Radzman NH, Ismail WI, Jaapar SS, Adam Z, Adam A. Stevioside from stevia rebaudiana Bertoni increases insulin sensitivity in 3T3-L1 adipocytes. Evid Based Complement Alternat Med 2013;2013:938081.
18. Sahu A, Sarkar PD. Comparative study of NBT reduction method for estimation of glycated protein (serum fructoseamine) with glycated HbA1c estimated on DCA 2000+analyzer (immunoagglutination inhibition). Indian J Physiol Pharmacol 2008;52:408-12.
19. Carter AW. Home fructosamine testing: is its demise premature? Diabetes Technol Ther 2002;4:643-4.
20. Hindle EJ, Rostron GM, Clark SA, Gatt JA. Serum fructosamine and glycated haemoglobin measurements in diabetic control. Arch Dis Child 1986;61:113-7.
21. Tahara Y, Shima K. Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diabetes Care 1995;18:440-7.
22. Abdel-Gayoum AG. The effect of glycemic control in type 2 diabetic patients with diabetes-related dyslipidemia. Saudi Med J 2004;25:207-11.
23. Gul A, Rahman MA, Hasnain SN. Influence of fructose concentration on myocardial infarction in senile diabetic and non-diabetic patients. Exp Clin Endocrinol Diabetes 2009; 117:605-9.
24. Serdarevic N, Pepic E, Musanovic J, Pleho-Kapic A. The serum fructosamine concentration at patients with diabetes mellitus. Health Med 2010;4:132-7.
25. Ko GT, Chan JC, Yeung VT, Chow CC, Tsang LW, Li JK, So WY, Wai HP, Cockram CS. Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects. Diabetes Care 1998;21:1221-5.
26. Weerasekera DS, Peiris H. The value of serum fructosamine in comparison with oral glucose tolerance test (OGTT) as a screening test for detection of gestational diabetes mellitus. J Obstet Gynaecol 2000;20:136-8.
27. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004;27:1487-95.
28. Choi ES, Rhee EJ, Kim JH, Won JC, Park CY, Lee WY, Oh KW, Park SW, Kim SW. Insulin sensitivity and insulin secretion determined by homeostasis model assessment and future risk of diabetes mellitus in Korean men. Korean Diabetes J 2008;32: 498-505.